What is Precision Medicine, will it benefit Aboriginal and Torres Strait Islander Peoples and what’s the next step?

by | Oct 11, 2020 | Key Thinkers Forum, Upcoming Event

Key Thinkers Forum – Tuesday, 27 October, 2020

Topic: What is Precision Medicine, will it benefit Aboriginal and Torres Strait Islander Peoples and what’s the next step?

Panel Members (Facilitated by Prof. Tom Calma AO)

  • Prof. Alex Brown
  • Greg Pratt
  • Emeritus Prof. Simon Easteal
  • Tiffany Boughtwood.

 Event Details:

Date: Tuesday, 27thOctober 2020
Time: 9.30am – 12.00pm
Location: Via Zoom Link
To Be Sent at Later Date

Contact Details:

Phone:  02 9114 0829
Email:    poche.admin@sydney.edu.au

This Key Thinkers Forum will be asking:

What is precision medicine and can it benefit Aboriginal and Torres Strait Islander peoples?

Precision medicine involves tailoring medical treatment to the individual characteristics of each patient, based on their genetic makeup. It is poised to transform rare disease and cancer management – in the populations where sufficient genomic data exists – to inform diagnosis and is the gold standard treatment of rare disease and cancers. Aboriginal and Torres Strait Islander peoples cannot access precision medicine in the same way as other Australians because there is no Aboriginal and Torres Strait Islander genomic data in the international database gnomAD. Aboriginal people have an average ten year shorter life expectancy than non-Aboriginal people. Access to the latest therapies is critical to closing the gap in health outcomes.

OPENING

Tiffany Boughtwood

Alex Brown

Simon Easteal

Greg Pratt

Daniel MacArthur

Poche Opinion

Pin It on Pinterest

Share This